1 Min Read
Aug 12 (Reuters) - Biosyent Inc :
* Q2 2016 net revenues of $4.4 million, up 22% versus Q2 2015
* Biosyent Inc says Q2 fully diluted EPS was $0.07 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.